DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Gaziano JM, Brotons C, Coppolecchia R. et al.
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
Lancet 2018;
392: 1036-1046
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.